Autopsy report · NCT01289639

Insulin Resistance in Non-alcoholic Fatty Liver Disease

“Low recruitment in intervention study. Baseline data published.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 years 3 months after it had already started.
• Ran for about 8 years 10 months before it stopped.
• 11 participants enrolled.
• Results were posted on the registry 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

VA Office of Research and Development

Sponsor type

US federal agency

Conditions

Fatty Liver

Interventions

fenofibrate; pioglitazone; placebo

Participants

11

Sites

1

Countries

United States

Trials that died the same way

• Effects of Self-administration of Medication During Hospitalization on Medication Safety, Adherence, and Patient Satisfaction in Dutch Hospitals
  “Difficult recruitment, despite several interventions.” (73% match in meaning)
• Multifactorial Pre-operative Intervention in Diabetes Mellitus
  “Inadequate participant recruitment” (70% match in meaning)
• Management of Participants With Low-level Persistent Viremia (ANRS 161 L-VIR)
  “Low recruitment of participants for the study” (70% match in meaning)
• Feasibility of Using Depth-of-sedation Measuring Equipment (BIS) to Guide Awake Fibreoptic Intubation
  “Difficulty in Recruitment due to lack of investigators and suitable patients” (69% match in meaning)
• NYCHA Mindfulness-based Smoking Cessation Intervention
  “Due to the pandemic's impacts on being able to conduct the intervention for this study, unable to begin recruitment.” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.